Roche looking for new place to test Covid-19 pill after cases plummet in UK
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Roche looking for new place to test Covid-19 pill after cases plummet in UK

Coronavirus chronicle

Reuters
21 April, 2021, 07:50 pm
Last modified: 21 April, 2021, 07:57 pm

Related News

  • North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Shanghai detects new infections after five days of 'zero Covid'
  • North Korea hails 'good results' on Covid as fever cases pass 2 million
  • China relaxes some Covid test rules for US, other travellers
  • New York Times pauses return to office for workers

Roche looking for new place to test Covid-19 pill after cases plummet in UK

Roche and Boston-based partner Atea Pharmaceuticals are hoping their AT-527 pill could offer an anti-viral therapy to treat Covid-19 patients that would be easier to administer and cheaper than other prospective treatments, such as antibody cocktails or Gilead Science's remdesivir

Reuters
21 April, 2021, 07:50 pm
Last modified: 21 April, 2021, 07:57 pm
The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014/ Reuters
The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014/ Reuters

Roche is looking for another location to carry out trials of its pill to fight Covid-19, after plummeting case numbers in Britain made it difficult to find enough patients for its study there, the Swiss drugmaker said on Wednesday.

Roche and Boston-based partner Atea Pharmaceuticals are hoping their AT-527 pill could offer an anti-viral therapy to treat Covid-19 patients that would be easier to administer and cheaper than other prospective treatments, such as antibody cocktails or Gilead Science's remdesivir.

In an interview in Swiss media in early March, Roche Chairman Christoph Franz had offered the tantalizing prospect of data on AT-527 "within the next weeks", saying he dreamed of being able to fight the pandemic with a pill by year's end.

But Britain's success in reducing case numbers with a swift vaccination programme and strict lockdown meant it was taking longer than expected to collect data from the trial there, said Bill Anderson, head of Roche's pharmaceutical division.

"There's just simply not enough patients to enrol...with the speed we were hoping for," Anderson said on a conference call.

"That's been one of the challenges since the beginning of the pandemic: you set up sites where there's a lot of Covid, and then by the time you're ready to enrol, the pandemic has moved somewhere else and you're sort of chasing it."

He did not identify other locations where Roche might set up trials.

Atea received an upfront payment of $350 million in cash from Roche, with potential for future milestone payments and royalties. With Roche, Atea is trialling the medicine in patients with mild to moderate Covid-19. It is also separately trialling the medicine in hospitals with patients with more severe cases.

Top News

Roche / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • US growth seen outpacing China’s for first time since 1976
    US growth seen outpacing China’s for first time since 1976
  • Students suffer over costlier food at public university canteens
    Students suffer over costlier food at public university canteens
  • A worker displays grains of wheat at a mill in Beirut, Lebanon, March 1, 2022. REUTERS/Mohamed Azakir/File Photo
    Russia can offer 25 mln tonnes of grain for export starting on 1 Aug: UN envoy

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Shanghai detects new infections after five days of 'zero Covid'
  • North Korea hails 'good results' on Covid as fever cases pass 2 million
  • China relaxes some Covid test rules for US, other travellers
  • New York Times pauses return to office for workers

Features

Mohammad (Mejbah) Mejbahuddin, Former Senior Secretary, Economic Relations Division (ERD), Ministry of Finance, Government of Bangladesh. TBS Sketch

‘No project is being delayed too long at the moment’

4h | Panorama
Dr Shamsul Hoque, Professor, Civil Engineering, BUET. TBS Sketch

‘Planning commission only in the name, there are no planners’ 

4h | Panorama
Masrur Reaz. TBS Sketch

‘To ensure accountability, contract financing should be based on ‘performance based payments’

4h | Panorama
Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

8h | Panorama

More Videos from TBS

Ways to retain body fragrance

Ways to retain body fragrance

6h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

9h | Videos
How to prepare for a job

How to prepare for a job

10h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

22h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab